|1.||Di Girolamo, G: 2 articles (01/2001 - 01/2000)|
|2.||Martí, M L: 2 articles (01/2001 - 01/2000)|
|3.||de los Santos, A R: 2 articles (01/2001 - 01/2000)|
|4.||Pérez Macri, S: 1 article (01/2001)|
|5.||Zmijanovich, R: 1 article (01/2001)|
|6.||Palomino, G: 1 article (01/2000)|
|7.||Godoy, M I: 1 article (01/2000)|
|8.||Greggio, A: 1 article (01/2000)|
|9.||Fandiño, D: 1 article (01/2000)|
|10.||Morano, M A: 1 article (01/2000)|
01/01/1999 - "The aim of this study was to assess the efficacy and tolerance of propinox administered i.v., and establish a dose-response relation according to three dose levels (10, 20 and 30 mg), vs. placebo in patients with moderate to severe acute biliary pain. "
01/01/2000 - "The 120 min evaluation revealed that 47.7% of patients treated with propinox 10 mg were free from pain vs. 68.8% and 73.5% of those receiving 20 mg and 30 mg, respectively. "
01/01/2000 - "All treatments induced significant and progressive pain reduction as from the 20 min evaluation of 20.3% in the placebo group, 45% in the group treated with propinox 10 mg; 52% in the group receiving propinox 20 mg and 56% in the propinox 30 mg group. "
01/01/1999 - "The last control revealed that 28% of patients receiving placebo had no pain while 60% of patients treated with propinox 30 mg reported absence of pain with a statistically significant difference (p < 0.001). "
01/01/1999 - "All treatments induced significant and progressive pain reduction at all controls, but patients treated with 20 and 30 mg of propinox showed significantly lower pain intensity after 120 min compared to the placebo group. "
|2.||Dysmenorrhea (Menstrual Pain)
01/01/2001 - "Every night, the patients recorded the average intensity of menstrual pain during the first 4 days of menstruation in a diary The follow-up visit carried out at day 5 showed significant reduction in pain intensity with both active treatments vs. the other two phases: baseline: 2.72 +/- 0.61; placebo: 1.85 +/- 0.87; lysine clonixinate plus propinox 1.36 +/- 0.81, and paracetamol plus hyosine N-butylbromide: 1.45 +/- 0.87. "
|3.||Colic (Abdominal Cramps)
01/01/1999 - "The results of this study showed that propinox was an effective drug in the treatment of moderate to severe colic pain of biliary origin. "
01/01/2000 - "The aim of this double-blind study was to assess the efficacy and tolerability of propinox administered i.v. and to establish a dose-response relationship according to three dose levels (10 mg, 20 mg and 30 mg), vs. placebo in patients with moderate-to-severe acute intestinal colic pain. "
01/01/2000 - "Propinox in intestinal colic: multicenter randomized prospective double-blind study of three doses of propinox vs. placebo in acute intestinal colic pain."
01/01/1999 - "Propinox in biliary colic: a multicenter, randomized, prospective and parallel double-blind study of three doses of propinox versus placebo in acute biliary colic pain."
01/01/2001 - "Active treatments revealed significantly higher analgesic efficacy from the outset compared with baseline and placebo; however, only the lysine clonixinate plus propinox combination reached a statistically significant difference by days 3 and 4. No changes in duration or intensity of menstrual bleeding or in the incidence of adverse effects were observed during the four study periods."